Insider Selling: Chemed Corp. (CHE) VP Sells $228,361.00 in Stock
Chemed Corp. (NYSE:CHE) VP Naomi C. Dallob sold 950 shares of the firm’s stock in a transaction dated Monday, November 27th. The shares were sold at an average price of $240.38, for a total transaction of $228,361.00. Following the completion of the transaction, the vice president now directly owns 9,747 shares in the company, valued at approximately $2,342,983.86. The sale was disclosed in a document filed with the SEC, which is accessible through this link.
Chemed Corp. (CHE) opened at $245.45 on Thursday. Chemed Corp. has a 1 year low of $148.19 and a 1 year high of $245.90. The firm has a market cap of $3,862.81, a PE ratio of 29.80, a P/E/G ratio of 5.12 and a beta of 1.14. The company has a debt-to-equity ratio of 0.15, a current ratio of 0.50 and a quick ratio of 0.48.
Chemed (NYSE:CHE) last announced its quarterly earnings results on Thursday, October 26th. The company reported $2.15 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $2.00 by $0.15. Chemed had a net margin of 4.62% and a return on equity of 27.69%. The business had revenue of $417.40 million for the quarter, compared to analysts’ expectations of $414.34 million. During the same quarter last year, the firm earned $1.73 EPS. The firm’s revenue for the quarter was up 6.3% compared to the same quarter last year. equities analysts expect that Chemed Corp. will post 4.73 earnings per share for the current year.
The company also recently announced a quarterly dividend, which will be paid on Monday, December 4th. Shareholders of record on Monday, November 13th will be given a dividend of $0.28 per share. The ex-dividend date is Friday, November 10th. This represents a $1.12 annualized dividend and a dividend yield of 0.46%. Chemed’s dividend payout ratio is currently 24.89%.
Institutional investors have recently bought and sold shares of the business. APG Asset Management N.V. bought a new position in shares of Chemed during the 3rd quarter worth approximately $5,657,000. Chicago Equity Partners LLC lifted its position in shares of Chemed by 88.5% during the 2nd quarter. Chicago Equity Partners LLC now owns 17,530 shares of the company’s stock worth $3,585,000 after buying an additional 8,230 shares in the last quarter. American Century Companies Inc. bought a new position in shares of Chemed during the 2nd quarter worth approximately $4,201,000. Strs Ohio lifted its position in shares of Chemed by 5.6% during the 2nd quarter. Strs Ohio now owns 1,900 shares of the company’s stock worth $388,000 after buying an additional 100 shares in the last quarter. Finally, Pinebridge Investments L.P. lifted its position in shares of Chemed by 66.6% during the 2nd quarter. Pinebridge Investments L.P. now owns 3,544 shares of the company’s stock worth $725,000 after buying an additional 1,417 shares in the last quarter. 97.72% of the stock is currently owned by hedge funds and other institutional investors.
CHE has been the topic of several recent research reports. TheStreet raised shares of Chemed from a “c+” rating to an “a-” rating in a research report on Friday, October 27th. Zacks Investment Research raised shares of Chemed from a “hold” rating to a “buy” rating and set a $213.00 price target on the stock in a research report on Wednesday, August 23rd. Royal Bank Of Canada reaffirmed a “hold” rating and issued a $209.00 price target on shares of Chemed in a research report on Friday, September 1st. KeyCorp reaffirmed a “hold” rating on shares of Chemed in a research report on Friday, October 27th. Finally, BidaskClub cut shares of Chemed from a “buy” rating to a “hold” rating in a research report on Wednesday, August 2nd. Three investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The company presently has a consensus rating of “Hold” and an average price target of $236.00.
Chemed Corporation purchases, operates and divests subsidiaries engaged in various business activities. The Company operates through two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company’s VITAS provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers.
Receive News & Ratings for Chemed Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed Corp. and related companies with MarketBeat.com's FREE daily email newsletter.